Business
VSee Powers Groundbreaking NIH Stroke Recovery Study in Phase 3 Clinical Trial
SAN JOSE, Calif., June 23, 2025--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors
About this update from Vsee Health, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/dfe01364d306961db2a3559ce85c93c1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RlOERkl4OwYQ9iV_SDUQQw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/dfe01364d306961db2a3559ce85c93c1","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/wX0uGR5bpl0ZgGyF8Mu8UQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/dfe01364d306961db2a3559ce85c93c1","width":1024,"height":512}},"lazy":false},{"type":"text","content":"SAN JOSE, Calif., June 23, 2025--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke survivors while reducing costs like transportation, caregiver burdens, and hospital readmissions.","length":605,"tagName":"p"},{"type":"text","content":"The proven efficacy of Phase 3 trials opens doors for Medicare and private payer reimbursement and opportunities in the $328M global stroke rehab market, where telehealth could disrupt traditional physical therapy with better adherence and lower costs. Success also paves the way for gamified telerehabilitation in other areas, e.g. multiple sclerosis, spinal cord injury, and traumatic brain injury rehab.","length":406,"tagName":"p"},{"type":"text","content":"Professor of neurology at UCLA and a co-principal investigator, Dr. Steven Cramer, MD affirms, "Reaching Phase 3 in a clinical trial of this scale is a hard-won milestone that has been twelve years in the making—one that wouldn’t have been possible without the right partners. VSee Health’s HIPAA-compliant platform has been instrumental in ensuring secure, seamless delivery of our interventions—critical for maintaining compliance and engagement in a large-scale trial like this."","length":...